## EFX: Equifax, Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 1.05 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($199.22)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Raymond James Financial Forecasts Strong Price Appreciation for Enerflex (TSE:EFX) Stock**
- Source: MarketBeat | 20251209T200836 | Bullish | Relevance: 99%
- Raymond James Financial has increased its price target for Enerflex (TSE:EFX) to C$24.50, suggesting a potential upside of 16.89%. This follows multiple analyst upgrades, contributing to a "Moderate Buy" consensus rating and an average price target of C$20.91. The article also notes recent insider buying, with Paul Mahoney doubling his stake in the company.

**2. Equifax (EFX) Stock Performance 2025: Declines vs. Industrial Sector Benchmarks - News and Statistics**
- Source: IndexBox | 20251208T120827 | Neutral | Relevance: 98%
-  Equifax Inc. (EFX) stock has significantly underperformed the broader industrial sector benchmarks in 2025, with declines of 17% year-to-date and 18.9% over the past 52 weeks, contrasting sharply with the Industrial Select Sector SPDR Fund's (XLI) gains. Despite reporting better-than-expected Q3 financial results including a 7.2% year-over-year revenue growth and 10.3% increase in adjusted EPS, the stock experienced only a marginal dip initially before mild positive momentum. EFX also underperformed a peer like TransUnion (TRU).

**3. Marshall Wace LLP Makes New Investment in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251209T121121 | Neutral | Relevance: 98%
-  Marshall Wace LLP has made a new investment in Equifax, Inc. (NYSE:EFX), acquiring 84,383 shares valued at approximately $21.9 million. Other institutional investors like Price T Rowe Associates Inc. MD and Norges Bank also adjusted their holdings, resulting in 96.20% of EFX being owned by institutional investors and hedge funds. Despite significant institutional buying, insiders have been net sellers, offloading 54,270 shares worth about $12.6 million in the past 90 days.

**4. Equifax, Inc. $EFX Shares Sold by Federated Hermes Inc.**
- Source: MarketBeat | 20251209T100808 | Neutral | Relevance: 98%
-  Federated Hermes Inc. reduced its stake in Equifax, Inc. by 23.6% in the second quarter, selling 69,000 shares. Several other institutional investors also adjusted their holdings in Equifax, with a total of 96.20% of the company's stock owned by institutional investors. Insiders also sold a significant number of shares, while analysts have a "Moderate Buy" consensus rating for EFX with an average target price of $276.40.

**5. WINTON GROUP Ltd Makes New Investment in Equifax, Inc. $EFX**
- Source: MarketBeat | 20251208T130808 | Somewhat-Bullish | Relevance: 98%
-  WINTON GROUP Ltd recently acquired a new stake of 17,623 shares in Equifax for approximately $4.57 million, contributing to institutional ownership exceeding 96%. Equifax outperformed Q3 estimates with $2.04 EPS and $1.54 billion revenue, while setting optimistic guidance for Q4 and FY2025. Despite recent insider selling, the company announced a quarterly dividend of $0.50 per share.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | BMO Capital | $234 | $245 | -4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | BMO Capital | main | Market Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 2 ($0.90M) |
| Sells | 5 ($1.53M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+2.1%)
- Capital Internationa: 8.5% (-0.4%)
- Blackrock Inc.: 7.5% (+1.4%)
- Price (T.Rowe) Assoc: 4.9% (+1.0%)
- Harris Associates L.: 4.8% (+14.2%)

### Key Risks

1. Long-term trend broken: trading 14.1% below SMA200.
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.05 suggests fair value with growth premium. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.8B |
| Beta | 1.59 |
| 52W Range | $199.98 - $281.07 |
| Short Interest | 3.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.05 |
| Forward P/E | 23.7 |
| Current P/E | 27.5 |
| YoY Growth | 16.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.9% over 5 days). Below STRENGTH zone by 6.3pp (needs >4.0% for momentum thesis). Below SMA200 (0.86x), long-term trend not supportive. MACD histogram positive (0.95), confirming momentum. RSI neutral at 43.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.34% (CS: 41) | Weak |
| RSI_14 | 43.0 | Neutral |
| MACD Histogram | 0.95 | Bullish |
| vs SMA20 | 0.998x | Below |
| vs SMA50 | 0.952x | Below |
| vs SMA200 | 0.859x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $209.02
- **Stop Loss:** $199.22 (4.7% risk)
- **Target:** $228.62 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 51
- **Position Value:** $10,660.02
- **Portfolio %:** 10.66%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-05 (Est: $2.04)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.94 | $2.04 | +5.3% |
| 2025Q2 | $1.92 | $2.00 | +4.1% |
| 2025Q1 | $1.40 | $1.53 | +9.0% |
| 2024Q4 | $2.10 | $2.12 | +1.1% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*